Isodiol International Inc Share Price Other OTC
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 1.91Cr 159.77Cr | Sales 2019 | 2.22Cr 185.74Cr | Capitalization | 5Cr 417.08Cr |
---|---|---|---|---|---|
Net income 2018 | -3.6Cr -300.55Cr | Net income 2019 | -13Cr -1.05TCr | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 1.55Cr 129.82Cr | Net Debt 2019 | 52.22L 44Cr | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/19/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Director/Board Member | - | 21/18/21 |
1st Jan change | Capi. | |
---|---|---|
+41.50% | 620.2Cr | |
-22.89% | 410.15Cr | |
+9.36% | 341.34Cr | |
-19.39% | 282.85Cr | |
-11.05% | 228.73Cr | |
+45.24% | 193.38Cr | |
-7.51% | 152.18Cr | |
+46.81% | 151.47Cr | |
-18.04% | 149.42Cr |